[Treatment of hepatocellular carcinoma with tamoxifen].
作者信息
Raoul J L
机构信息
Centre Eugène-Marquis, Rennes.
出版信息
Gastroenterol Clin Biol. 1996 Mar;20(2):221-2.
PMID:8761695
Abstract
摘要
相似文献
1
[Treatment of hepatocellular carcinoma with tamoxifen].
Gastroenterol Clin Biol. 1996 Mar;20(2):221-2.
2
[Tamoxifen and hepatocellular carcinoma: verdict after enthusiasm...].
Gastroenterol Clin Biol. 1996;20(6-7):609-10.
3
Tamoxifen does not improve overall survival in people with advanced-stage hepatocellular carcinoma.
Cancer Treat Rev. 2005 Oct;31(6):491-5. doi: 10.1016/j.ctrv.2005.07.005. Epub 2005 Oct 7.
4
Re: Liu et al.--Estrogen receptor status in inoperable hepatocellular carcinoma.
Am J Gastroenterol. 2001 Apr;96(4):1297-8. doi: 10.1111/j.1572-0241.2001.03720.x.
5
Tamoxifen in hepatocellular carcinoma.
Lancet. 1998 Sep 5;352(9130):819-20. doi: 10.1016/S0140-6736(05)60715-5.
6
Tamoxifen for the treatment of malignancies other than breast and endometrial carcinoma.
Semin Oncol. 1997 Feb;24(1 Suppl 1):S1-65-S1-70.
7
[Complete remission of hepatocarcinoma metastasis during palliative treatment with tamoxifen].
Radiol Med. 1998 Sep;96(3):263-5.
8
Complete regression of hepatocellular carcinoma under tamoxifen.
Am J Gastroenterol. 2000 Mar;95(3):827-9. doi: 10.1111/j.1572-0241.2000.01895.x.
9
[Does anti-estrogen therapy after estrogen receptor analysis have value in palliative therapy of hepatocellular carcinoma?].
Z Gastroenterol. 1998 Jul;36(7):605-7.
10
Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study.
Am J Gastroenterol. 2000 Jan;95(1):218-22. doi: 10.1111/j.1572-0241.2000.01688.x.
Zotero 插件